Thermo Fisher Scientific (TMO) Equity Ratio (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Equity Ratio for 18 consecutive years, with 0.46 the latest figure, recorded in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.46, down 8.01% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.46 (down 8.01% YoY), and the FY2025 annual result was 0.48, down 4.92% from the prior year.
• Equity Ratio was 0.46 for Q1 2026 at Thermo Fisher Scientific, down from 0.48 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.51 in Q4 2024 and troughed at 0.44 in Q2 2022.
• Average Equity Ratio over 5 years is 0.48, with a median of 0.47 recorded in 2023.
• Year-over-year, Equity Ratio fell 16.85% in 2022 and increased 7.58% in 2024.
• Over 5 years, Equity Ratio stood at 0.45 in 2022, then advanced by 4.42% to 0.47 in 2023, then increased by 7.58% to 0.51 in 2024, then dropped by 4.92% to 0.48 in 2025, then fell by 5.29% to 0.46 in 2026.
• Per Business Quant data, the three most recent Equity Ratio figures were 0.46 in Q1 2026, 0.48 in Q4 2025, and 0.5 in Q3 2025.